Vaccination

Novavax delays Covid vaccine authorization request

US biotech firm Novavax on Monday said it had delayed plans to seek authorization for its Covid vaccine candidate, a setback for developing countries hoping the injection would soon be available.

Diseases, Conditions, Syndromes

Malaria vaccine 'first to meet WHO efficacy target'

A malaria vaccine candidate tested on children in West Africa has shown an efficacy of around 77 percent, say scientists, hailing it as a breakthrough in the fight against the disease.

Pediatrics

Novavax starts COVID-19 vaccine trials on children

US biotech firm Novavax said Monday it had started clinical trials of its proposed COVID-19 vaccine on children, in a program that will involve up to 3,000 adolescents aged 12-17.

page 7 from 40